Department of Neurosurgery, University of Tokyo Hospital, Tokyo, Japan.
Department of Neurosurgery, University of Tokyo Hospital, Tokyo, Japan; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota.
Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):1126-1134. doi: 10.1016/j.ijrobp.2023.02.059. Epub 2023 Mar 11.
Because patients with untreated brain arteriovenous malformations (BAVMs) are at variable risks of cerebral hemorrhage and associated mortality and morbidity, it is essential to identify patient populations who benefit most from prophylactic interventions. This study aimed to examine age-dependent differences in the therapeutic effect of stereotactic radiosurgery (SRS) on BAVMs.
This retrospective observational study enrolled patients with BAVMs who underwent SRS at our institution between 1990 and 2017. The primary outcome was post-SRS hemorrhage, and the secondary outcomes included nidus obliteration, post-SRS early signal changes, and mortality. To investigate age-related differences in outcomes after SRS, we performed age-stratified analyses using the Kaplan-Meier analysis and weighted logistic regression with the inverse probability of censoring weighting (IPCW). To address significant differences in patient baseline characteristics, we also performed inverse probability of treatment weighting (IPTW) adjusted for possible confounders to investigate age-related differences in outcomes after SRS.
A total of 735 patients with 738 BAVMs were stratified by age. Age-stratified analysis using a weighted logistic regression model with IPCW showed a direct correlation between patient age and post-SRS hemorrhage (odds ratio [OR], 95% confidence interval [CI], and P value: 2.20, 1.34-3.63, and .002 at 18 months; 1.86, 1.17-2.93, and .008 at 36 months; and 1.61, 1.05-2.48, and .030 at 54 months, respectively). The age-stratified analysis also showed an inverse relationship between age and obliteration over the first 42 months after SRS (OR, 95% CI, and P value: 0.05, 0.02-0.12, and <.001 at 6 months; 0.55, 0.44-0.70, and <.001 at 24 months; and 0.76, 0.63-0.91, and .002 at 42 months, respectively). These results were also confirmed with the IPTW analyses.
Our analysis demonstrated that patients' age at SRS is significantly associated with hemorrhage and the nidus obliteration rate after treatment. In particular, younger patients are more likely to exhibit reduced cerebral hemorrhages and achieve earlier nidus obliteration compared with older patients.
由于未经治疗的脑动静脉畸形(BAVM)患者存在脑出血及相关死亡率和发病率的可变风险,因此确定最受益于预防性干预的患者人群至关重要。本研究旨在研究立体定向放射外科(SRS)对 BAVM 的治疗效果随年龄的差异。
本回顾性观察性研究纳入了 1990 年至 2017 年期间在我院接受 SRS 治疗的 BAVM 患者。主要结局是 SRS 后出血,次要结局包括灶闭塞、SRS 后早期信号变化和死亡率。为了研究 SRS 后结局与年龄的关系,我们使用 Kaplan-Meier 分析和逆概率加权(IPCW)的加权逻辑回归进行了年龄分层分析。为了解决患者基线特征的显著差异,我们还使用倾向评分逆加权(IPTW)调整了可能的混杂因素,以研究 SRS 后结局与年龄的关系。
735 例 738 个 BAVM 患者按年龄分层。使用 IPCW 加权逻辑回归模型的年龄分层分析显示,患者年龄与 SRS 后出血直接相关(优势比[OR],95%置信区间[CI]和 P 值:18 个月时为 2.20(1.34-3.63),.002;36 个月时为 1.86(1.17-2.93),.008;54 个月时为 1.61(1.05-2.48),.030)。年龄分层分析还显示,SRS 后前 42 个月内年龄与闭塞呈负相关(OR,95%CI 和 P 值:6 个月时为 0.05(0.02-0.12),.001;24 个月时为 0.55(0.44-0.70),.001;42 个月时为 0.76(0.63-0.91),.002)。这些结果也得到了 IPTW 分析的证实。
我们的分析表明,SRS 时患者的年龄与治疗后出血和灶闭塞率显著相关。具体而言,与年龄较大的患者相比,年龄较小的患者更有可能减少脑出血并更早实现灶闭塞。